Sartor, A. O., Emmett, L., Fizazi, K. O., Iagaru, A., Kiess, A. P., Matsubara, N., Piulats, J. M., Saad, F., Tagawa, S. T., Wei, X. X., Tang, J., Alanee, S., Calais, J. (2026). AcTFirst: A phase 3 trial of
                    <sup>225</sup>
                    Ac-PSMA-617 plus ARPI versus standard of care in adults with PSMA-positive metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5134